Risek IV 40 mg is a proton pump inhibitor (PPI) containing omeprazole sodium, formulated as a lyophilized powder for intravenous injection or infusion. It is used for short-term treatment of acid-related gastrointestinal conditions when oral administration is not feasible./Description: Risek IV 40 mg (omeprazole sodium) is indicated for the short-term treatment (up to 5 days) of conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, NSAID-associated ulceration, duodenal ulcers, and Zollinger-Ellison syndrome in patients unable to take oral therapy. It is also used for the prophylaxis of acid aspiration during general anesthesia.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.